Abstract
CordenPharma, a German contract development and manufacturing organization, has completed a 3,000 L expansion of its solid-phase peptide plant in Boulder, Colorado, bringing capacity at the site to 13,000 L. The new capacity allows the firm to manufacture 400 kg of a complex, long peptide per single batch, according to Matthieu Giraud, the firm’s director of peptide, lipid, and carbohydrate operations. The site also features a 100 cm high-pressure reverse-phase purification column.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
